{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:14:56Z","timestamp":1784945696442,"version":"3.55.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004070","name":"Khalifa University of Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.biochi.2021.02.012","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T22:11:09Z","timestamp":1614204669000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-8304","authenticated-orcid":false,"given":"Mayssa","family":"Hachem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biochi.2021.02.012_bib1","first-page":"1686","article-title":"Zoonotic origins of human coronaviruses","volume":"16","author":"Ye","year":"2020","journal-title":"In-ternational J. Biol. Sci."},{"key":"10.1016\/j.biochi.2021.02.012_bib2","series-title":"Coronavirus Disease 2019","first-page":"141","article-title":"Classical coronaviruses","author":"Jaiswal","year":"2020"},{"issue":"4","key":"10.1016\/j.biochi.2021.02.012_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.15698\/cst2020.04.216","article-title":"Coronavirus infections: epidemiological, clinical and immunological features and hypotheses","volume":"4","author":"Raoult","year":"2020","journal-title":"Cell Stress"},{"issue":"4","key":"10.1016\/j.biochi.2021.02.012_bib4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/jcm9040967","article-title":"A\u00a0systematic review of COVID-19 epidemiology based on current evidence","volume":"9","author":"Park","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.biochi.2021.02.012_bib5","series-title":"British Medical Journal Publishing Group","article-title":"Covid-19: new coronavirus variant is identified in UK","author":"Wise","year":"2020"},{"issue":"5","key":"10.1016\/j.biochi.2021.02.012_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J.\u00a0Heart Lung Transplant. : Off. Publ. Int. Soc. Heart Transplantation"},{"issue":"6","key":"10.1016\/j.biochi.2021.02.012_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.biochi.2021.02.012_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.biochi.2021.02.012_bib9","first-page":"9","article-title":"Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management","volume":"8","author":"Liu","year":"2020","journal-title":"J.\u00a0Transl. Internal Med."},{"issue":"6891","key":"10.1016\/j.biochi.2021.02.012_bib10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"issue":"43","key":"10.1016\/j.biochi.2021.02.012_bib11","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A\u00a0human homolog of angioten-sin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2021.02.012_bib12","series-title":"Sofosbuvir Protects Human Brain Organoids against SARS-CoV-2. bioRxiv","author":"Mesci","year":"2020"},{"key":"10.1016\/j.biochi.2021.02.012_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/geno.1997.4845","article-title":"Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3","volume":"44","author":"Paoloni-Giacobino","year":"1997","journal-title":"Genomics"},{"issue":"11","key":"10.1016\/j.biochi.2021.02.012_bib14","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3201\/eid1011.040516","article-title":"Nucleocapsid protein as early diagnostic marker for SARS","volume":"10","author":"Che","year":"2004","journal-title":"Emerg. Infect. Dis."},{"issue":"7","key":"10.1016\/j.biochi.2021.02.012_bib15","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1128\/JVI.01472-06","article-title":"Role of the coronavirus E viroporin protein transmembrane domain in virus assembly","volume":"81","author":"Ye","year":"2007","journal-title":"J.\u00a0Virol."},{"issue":"4","key":"10.1016\/j.biochi.2021.02.012_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2217\/fvl-2018-0144","article-title":"Membrane binding proteins of coronaviruses","volume":"14","author":"J Alsaadi","year":"2019","journal-title":"Future Virol."},{"issue":"10","key":"10.1016\/j.biochi.2021.02.012_bib17","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/jmv.20953","article-title":"The membrane protein of SARS-CoV suppresses NF-\u03baB activation","volume":"79","author":"Fang","year":"2007","journal-title":"J.\u00a0Med. Virol."},{"issue":"8","key":"10.1016\/j.biochi.2021.02.012_bib18","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1021\/acsinfecdis.0c00168","article-title":"Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease","volume":"6","author":"Freitas","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.biochi.2021.02.012_bib19","article-title":"SARS-Coronavirus-2 Nsp13 possesses NTPase and RNA helicase activities that can Be inhibited by bismuth salts","volume":"1","author":"Shu","year":"2020","journal-title":"Virol. Sin."},{"key":"10.1016\/j.biochi.2021.02.012_bib20","first-page":"137","article-title":"Structure-function relationships among RNA- dependent RNA polymerases","volume":"320","author":"Ng","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.biochi.2021.02.012_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41582-020-0398-3","article-title":"Lifting the mask on neurological manifestations of COVID-19","volume":"16","author":"Pezzini","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.biochi.2021.02.012_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008434","article-title":"A\u00a0viral journey to the brain: current considerations and future developments","volume":"16","author":"Ayala-Nunez","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biochi.2021.02.012_bib23","series-title":"Lippincott Williams & Wilkins Health, Philadelphia, PA","article-title":"Fields virology, wolters kluwer","author":"Knipe","year":"2013"},{"issue":"6","key":"10.1016\/j.biochi.2021.02.012_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.tim.2012.03.009","article-title":"Viral disruption of the blood\u2013brain barrier","volume":"20","author":"Spindler","year":"2012","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.biochi.2021.02.012_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fmicb.2020.00214","article-title":"The mechanism of the zika virus crossing the placental barrier and the blood-brain barrier","volume":"11","author":"Chiu","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biochi.2021.02.012_bib26","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.3389\/fmicb.2017.02557","article-title":"Zika virus infects, activates, and crosses brain microvascular endothelial cells, without barrier disruption","volume":"8","author":"Papa","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biochi.2021.02.012_bib27","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3389\/fmicb.2019.02158","article-title":"Selective disruption of the blood-brain barrier by zika virus","volume":"10","author":"Leda","year":"2019","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.biochi.2021.02.012_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037886","article-title":"West Nile virus infection causes endocytosis of a specific subset of tight junction membrane proteins","volume":"7","author":"Xu","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.biochi.2021.02.012_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2008.11.047","article-title":"West Nile virus infection mod-ulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: transmigration across the in\u00a0vitro blood-brain barrier","volume":"385","author":"Verma","year":"2009","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.biochi.2021.02.012_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01476-14","article-title":"Viral patho-gen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals","volume":"5","author":"Daniels","year":"2014","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.biochi.2021.02.012_bib31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1172\/JCI88720","article-title":"Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection","volume":"127","author":"Daniels","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.biochi.2021.02.012_bib32","first-page":"1","article-title":"The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the res-piratory failure of COVID-19 patients:[e-pub ahead of print]","author":"Li","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"issue":"6","key":"10.1016\/j.biochi.2021.02.012_bib33","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000893","article-title":"Anti\u2013SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: studies in 8 stuporous and comatose patients","volume":"7","author":"Alexopoulos","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"issue":"12","key":"10.1016\/j.biochi.2021.02.012_bib34","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1007\/s12035-020-02094-y","article-title":"Understanding the immunologic characteristics of neurologic mani-festations of SARS-CoV-2 and potential immunological mechanisms","volume":"57","author":"Mohammadi","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biochi.2021.02.012_bib35","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"9","key":"10.1016\/j.biochi.2021.02.012_bib36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biochi.2021.02.012_bib37","series-title":"Brain, Behavior, and Immunity","article-title":"SARS-CoV-2:\u201cThree-steps\u201d infection model and CSF diagnostic implication","author":"Panciani","year":"2020"},{"key":"10.1016\/j.biochi.2021.02.012_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coviro.2014.12.009","article-title":"Viral diseases of the central nervous system","volume":"11","author":"Swanson","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.biochi.2021.02.012_bib39","first-page":"1","article-title":"The S1 protein of SARS-CoV-2 crosses the blood\u2013brain barrier in mice","author":"Rhea","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"15","key":"10.1016\/j.biochi.2021.02.012_bib40","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1021\/acschemneuro.0c00373","article-title":"Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms","volume":"11","author":"Hassanzadeh","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"8","key":"10.1016\/j.biochi.2021.02.012_bib41","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/jnnp-2020-323522","article-title":"Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke","volume":"91","author":"Al Saiegh","year":"2020","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.biochi.2021.02.012_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","article-title":"A\u00a0first case of meningi-tis\/encephalitis associated with SARS-Coronavirus-2","volume":"94","author":"Moriguchi","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.biochi.2021.02.012_bib43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","article-title":"Capture, crawl, cross: the T cell code to breach the blood\u2013brain barriers","volume":"33","author":"Engelhardt","year":"2012","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.biochi.2021.02.012_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2008.11.047","article-title":"West Nile virus infection mod-ulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: transmigration across the in\u00a0vitro blood-brain barrier","volume":"385","author":"Verma","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.biochi.2021.02.012_bib45","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biochi.2021.02.012_bib46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"Cytokine storm in COVID-19 and treatment","volume":"80","author":"Ye","year":"2020","journal-title":"J.\u00a0Infect."},{"issue":"6","key":"10.1016\/j.biochi.2021.02.012_bib47","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alz-heimer\u2019s Dement"},{"key":"10.1016\/j.biochi.2021.02.012_bib48","unstructured":"Naughton, S. X., Raval, U., & Pasinetti, G. M. Potential novel role of COVID-19 in Alzheimer\u2019s disease and preventative mitigation strategies. J. Alzheim. Dis., 1-5."},{"issue":"6","key":"10.1016\/j.biochi.2021.02.012_bib49","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.40071","article-title":"Cytokine storm syndrome: looking toward the precision medicine era","volume":"69","author":"Behrens","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.biochi.2021.02.012_bib50","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.biochi.2021.02.012_bib51","article-title":"The role of high cholesterol in age-related COVID19 lethality","author":"Wang","year":"2020","journal-title":"bioRxiv"},{"issue":"16","key":"10.1016\/j.biochi.2021.02.012_bib52","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"Jama"},{"key":"10.1016\/j.biochi.2021.02.012_bib53","series-title":"APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort","author":"Kuo","year":"2020"},{"key":"10.1016\/j.biochi.2021.02.012_bib54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fcell.2019.00313","article-title":"Neuroinflammation as a factor of neurodegenerative disease: thalidomide analogs as treatments","volume":"7","author":"Jung","year":"2019","journal-title":"Front. Cell Develop. Biol."},{"issue":"116923","key":"10.1016\/j.biochi.2021.02.012_bib55","article-title":"COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome","volume":"414","author":"Jain","year":"2020","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.biochi.2021.02.012_bib56","unstructured":"Altable, M., & de la Serna, J. M. Cerebrovascular disease in COVID-19: is there a higher risk of stroke?."},{"issue":"9","key":"10.1016\/j.biochi.2021.02.012_bib57","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/jcbfm.2012.88","article-title":"Inflammatory cytokines in experimental and human stroke","volume":"32","author":"Lambertsen","year":"2012","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.biochi.2021.02.012_bib58","series-title":"Seizures Associated with Coronavirus Infections","author":"Asadi-Pooya","year":"2020"},{"issue":"10","key":"10.1016\/j.biochi.2021.02.012_bib59","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.3390\/ijms21103544","article-title":"The role of lipid me-tabolism in COVID-19 virus infection and as a drug target","volume":"21","author":"Abu-Farha","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biochi.2021.02.012_bib60","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004820","article-title":"Role of lipids in virus replication","volume":"3","author":"Lorizate","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"10.1016\/j.biochi.2021.02.012_bib61","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.coviro.2012.09.006","article-title":"(+) RNA viruses rewire cellular pathways to build replication organelles","volume":"2","author":"Belov","year":"2012","journal-title":"Curr. Opinion Virol."},{"issue":"23","key":"10.1016\/j.biochi.2021.02.012_bib62","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.3390\/ijms20235952","article-title":"Lipidomic profiling reveals significant perturbations of intracellular lipid homeostasis in enterovirus-infected cells","volume":"20","author":"Yan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.biochi.2021.02.012_bib63","doi-asserted-by":"crossref","first-page":"E1782","DOI":"10.1073\/pnas.1418971112","article-title":"RNA virus replication depends on enrichment of phosphatidylethanolamine at replication sites in subcellular membranes","volume":"112","author":"Xu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"1","key":"10.1016\/j.biochi.2021.02.012_bib64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/v11010073","article-title":"Characterization of the lipidomic profile of human coronavirus-infected cells: implications for lipid metabolism remodeling upon coronavirus replication","volume":"11","author":"Yan","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.biochi.2021.02.012_bib65","article-title":"Can bioactive lipids inactivate coronavirus (COVID-19)?","author":"Das","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.biochi.2021.02.012_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56556-y","article-title":"Potential neuroprotective and anti-inflammatory effects provided by omega-3 (DHA) against Zika virus infection in human SH-SY5Y cells","volume":"9","author":"Braz-De-Melo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2021.02.012_bib67","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.biochi.2020.11.007","article-title":"Special section involvement of lipids in the occurrence of COVID-19","volume":"179","author":"Rioux","year":"2020","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.biochi.2021.02.012_bib68","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1073\/pnas.80.12.3581","article-title":"Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis","volume":"80","author":"Corey","year":"1983","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"6","key":"10.1016\/j.biochi.2021.02.012_bib69","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1172\/JCI111612","article-title":"Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils","volume":"74","author":"Lee","year":"1984","journal-title":"J.\u00a0Clin. Invest."},{"issue":"6","key":"10.1016\/j.biochi.2021.02.012_bib70","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1046\/j.1471-4159.1994.62062437.x","article-title":"Lipoxygenation of docosahexaenoic acid by the rat pineal body","volume":"62","author":"Sawazaki","year":"1994","journal-title":"J.\u00a0Neurochem."},{"issue":"1","key":"10.1016\/j.biochi.2021.02.012_bib71","first-page":"S305","article-title":"The structure-activity relationship of lipoxygenase products of long-chain polyunsaturated fatty acids: effects on human platelet aggregation","volume":"31","author":"Karanian","year":"1996","journal-title":"Lipids"},{"issue":"17","key":"10.1016\/j.biochi.2021.02.012_bib72","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"22","key":"10.1016\/j.biochi.2021.02.012_bib73","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1073\/pnas.0402531101","article-title":"Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress","volume":"101","author":"Mukherjee","year":"2004","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"7503","key":"10.1016\/j.biochi.2021.02.012_bib74","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biochi.2021.02.012_bib75","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","article-title":"A\u00a0role for do-cosahexaenoic acid\u2013derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"J.\u00a0Clin. Investigat."},{"issue":"4\u20136","key":"10.1016\/j.biochi.2021.02.012_bib76","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10571-006-9064-6","article-title":"The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling","volume":"26","author":"Bazan","year":"2006","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biochi.2021.02.012_bib77","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.178.1.496","article-title":"Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness","volume":"178","author":"Levy","year":"2007","journal-title":"J.\u00a0Immunol."},{"issue":"44","key":"10.1016\/j.biochi.2021.02.012_bib78","doi-asserted-by":"crossref","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"1","key":"10.1016\/j.biochi.2021.02.012_bib79","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1096\/fj.10-161836","article-title":"Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation","volume":"25","author":"Chen","year":"2011","journal-title":"Faseb. J."},{"issue":"1","key":"10.1016\/j.biochi.2021.02.012_bib80","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cell.2013.02.027","article-title":"The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza","volume":"153","author":"Morita","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biochi.2021.02.012_bib81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"issue":"8","key":"10.1016\/j.biochi.2021.02.012_bib82","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2\u2013nonsteroidal antiinflam-matory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"issue":"10","key":"10.1016\/j.biochi.2021.02.012_bib83","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1080\/15548627.2015.1078958","article-title":"Activation of autophagy in macrophages by pro-resolving lipid mediators","volume":"11","author":"Prieto","year":"2015","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.biochi.2021.02.012_bib84","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1753425916628618","article-title":"Resolvin D1, resolvin D2 and maresin 1 activate the GSK3\u03b2 anti-inflammatory axis in TLR4-engaged human monocytes","volume":"22","author":"Gu","year":"2016","journal-title":"Innate Immun."},{"issue":"2","key":"10.1016\/j.biochi.2021.02.012_bib85","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.chembiol.2012.11.010","article-title":"Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents","volume":"20","author":"Dalli","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biochi.2021.02.012_bib86","doi-asserted-by":"crossref","first-page":"18972","DOI":"10.1038\/srep18972","article-title":"Resolvin D4 stereo-assignment and its novel actions in host protection and bacterial clearance","volume":"6","author":"Winkler","year":"2016","journal-title":"Sci. Rep."},{"issue":"28","key":"10.1016\/j.biochi.2021.02.012_bib87","article-title":"Resolvin D1 and D2 reduce SARS-Cov-2-induced inflammation in cystic fibrosis macrophages","volume":"8","author":"Recchiuti","year":"2020","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.biochi.2021.02.012_bib88","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1007\/s12035-015-9228-9","article-title":"Efficient docosahexaenoic acid uptake by the brain from a structured phospholipid","volume":"53","author":"Hachem","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biochi.2021.02.012_bib89","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/nu12010251","article-title":"Do-cosahexaenoic acid (DHA) bioavailability in humans after oral intake of DHA-containing triacylglycerol or the structured phospholipid AceDoPC\u00ae","volume":"12","author":"Hachem","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biochi.2021.02.012_bib90","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biochi.2020.01.013","article-title":"Brain targeting with docosahex-aenoic acid as a prospective therapy for neurodegenerative diseases and its passage across blood brain barrier","volume":"170","author":"Hachem","year":"2020","journal-title":"Biochimie"},{"issue":"7501","key":"10.1016\/j.biochi.2021.02.012_bib91","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13241","article-title":"Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid","volume":"509","author":"Nguyen","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biochi.2021.02.012_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax7142","article-title":"Zika virus degrades the \u03c9-3 fatty acid transporter Mfsd2a in brain microvascular endothelial cells and impairs lipid homeostasis","volume":"5","author":"Zhou","year":"2019","journal-title":"Sci. Adv."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908421000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908421000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:18:25Z","timestamp":1759540705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908421000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":92,"alternative-id":["S0300908421000638"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2021.02.012","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2021.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}